NCT02267733View on ClinicalTrials.gov

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
InfluenzaGammopathy
Interventions
DRUG

Fluzone

Fluzone High-Dose will be administered with a planned booster at 30 days post initial administration

Trial Locations (1)

06519

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02267733 - Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients | Biotech Hunter | Biotech Hunter